GT Biopharma
GTBP
GTBP
36 hedge funds and large institutions have $5.63M invested in GT Biopharma in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.38% more ownership
Funds ownership: 0.27% → 0.65% (+0.38%)
Holders
36
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3M | |
| 2 | +$248K | |
| 3 | +$134K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$88.6K |
| 5 |
Renaissance Technologies
New York
|
+$41K |
Top Sellers
| 1 | -$44K | |
| 2 | -$31K | |
| 3 | -$26K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$23K |
| 5 |
BJL
Brighton Jones LLC
Seattle,
Washington
|
-$21K |